[Skip to the reading](#reading)  
[Queen Creek  Injection question cards](/)  Chapter index

Orient

- [Start with the question](/)
 
- [Your Queen Creek starting point](/start-here/)
 
- [The short version](/quick-card/)
 
- [What peptide means](/answer-cards/)
 
Check

- [Check the approval claim](/approval-cards/)
 
- [Understand custom medicines](/compounding-cards/)
 
- [Check a shortage explanation](/shortage-cards/)
 
- [Read a research label](/research-cards/)
 
- [The Arizona checks](/arizona-cards/)
 
- [Check the person’s licence](/licence-cards/)
 
- [Check the pharmacy](/pharmacy-cards/)
 
Choose the visit

- [What online care involves](/telehealth-cards/)
 
- [What a local visit involves](/in-person-cards/)
 
Count the cost

- [Read the whole price](/cost-cards/)
 
- [Ask what the plan pays](/coverage-cards/)
 
- [Fill the cost worksheet](/cost-question-cards/)
 
Bring questions

- [Check the medicine and follow-up](/safety-cards/)
 
- [Read a sales claim carefully](/warning-cards/)
 
- [Bring the visit questions](/question-cards/)
 
- [Official pages worth opening](/source-cards/)
 
Check

# A research label gives no plan for your care

“For research use only” means labelled for laboratory work. It does not mean an approved treatment for people.

## A research label does not make treatment approved

The US drug agency is called FDA, short for Food and Drug Administration.

 

FDA sent warning letters about peptide products sold for treatment but labelled for research. FDA said they were unapproved drugs. Letters checked September 26, 2026.

 

A warning letter tells a business what FDA believes it has done wrong. It is an accusation, not a court decision.
 
## A promising name can still lack approval

BPC-157, ipamorelin and retatrutide had no approved US medicines in the FDA records checked September 26, 2026.

 

Ask whether the exact medicine being offered has FDA approval. Ask about that medicine by name.
 
## Some ingredients cannot be used in custom medicines

FDA says federal law does not allow medicine made to order with retatrutide or cagrilintide. FDA guidance checked September 26, 2026.

 

Ask the health professional: “Is this medicine approved? If it is made to order, why is that allowed by law?” Ask for that explanation before asking how to get it.
 
## Keep the question about real care

- Is this medicine approved for use in people?

- Who will check my health and discuss treatment?

- Which pharmacy would fill the medicine order?

## Read the source for this question

- [FDA: weight-loss product concerns](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) 

Read the research-label and retatrutide sections for the agency’s stated position.

- [FDA: what a drug code cannot prove](https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory) 

Read why appearing on a drug list does not prove FDA approval.

[Previous card  Check a shortage explanation](/shortage-cards/)   [Next card  The Arizona checks  →](/arizona-cards/)
 
This is a guide beside your Queen Creek care questions; it has neither a clinic desk nor medicine to sell.

[Text version of this page](/research-cards/index.md)  [Guide text index](/llms.txt)  [Official reading list](/source-cards/)